Need documentation of process-related residual protein in final drug substance?

31 January 2019

Standard analyses don’t detect trace amounts of protein process additives (residual proteins). For instance growth factors, Benzonase nuclease, Protein A, enzymes for site-specific PEGylation, etc.

Instead you can now use a customized LC-MS assay to detect protein residuals of interest – in both your final drug substance and process samples.

Advantages include

  • low-to-sub ppm detection
  • id and quantification of key residuals

You can use the results for

  • FDA/EMA documentation of process-related residuals in final drug substance.
  • Evaluation of clearance throughout purification steps.
  • Process validation and establishment of batch acceptance criteria.

Alphalyse offers analysis development for your residual of interest, and analysis of both final drug substance and process samples. Above all, we perform low-to-sub ppm detection along with identification and quantification of key residual proteins.

Find out more